{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T10:34:01Z","timestamp":1791196441753,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["Grant K23HL089812"],"award-info":[{"award-number":["Grant K23HL089812"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1378\/chest.12-2081","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T10:06:09Z","timestamp":1365069969000},"page":"531-541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Use of Selective Serotonin Reuptake Inhibitors and Outcomes in Pulmonary Arterial Hypertension"],"prefix":"10.1016","volume":"144","author":[{"given":"Ali","family":"Sadoughi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari E.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana R.","family":"Preston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginny P.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah H.","family":"McCollister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harrison W.","family":"Farber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas S.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1378\/chest.12-2081_bib1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1164\/rccm.200210-1212OC","article-title":"Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension","volume":"168","author":"Marcos","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1378\/chest.12-2081_bib2","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/BF02147819","article-title":"Blood 5-hydroxytryptamine in rats with pulmonary hypertension produced by ingestion of Crotalaria spectabilis seeds","volume":"24","author":"Kay","year":"1968","journal-title":"Experientia"},{"issue":"9","key":"10.1378\/chest.12-2081_bib3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199608293350901","article-title":"Appetite-suppressant drugs and the risk of primary pulmonary hypertension","volume":"335","author":"Abenhaim","year":"1996","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1378\/chest.12-2081_bib4","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1161\/01.CIR.100.8.869","article-title":"Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension","volume":"100","author":"Rothman","year":"1999","journal-title":"Circulation"},{"issue":"3","key":"10.1378\/chest.12-2081_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0002-9343(99)80156-9","article-title":"Increased plasma serotonin in primary pulmonary hypertension","volume":"99","author":"Herv\u00e9","year":"1995","journal-title":"Am J Med"},{"issue":"2","key":"10.1378\/chest.12-2081_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bjp.0703570","article-title":"5-hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension","volume":"131","author":"MacLean","year":"2000","journal-title":"Br J Pharmacol"},{"issue":"5 pt 1","key":"10.1378\/chest.12-2081_bib7","first-page":"L795","article-title":"A new role for an old molecule: serotonin as a mitogen","volume":"272","author":"Fanburg","year":"1997","journal-title":"Am J Physiol"},{"issue":"3","key":"10.1378\/chest.12-2081_bib8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1164\/rccm.200302-264OC","article-title":"Proliferation and signaling in fibroblasts: role of 5-hydroxytryptamine2A receptor and transporter","volume":"170","author":"Welsh","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"10.1378\/chest.12-2081_bib9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/bjp.2008.241","article-title":"Pulmonary hypertension: therapeutic targets within the serotonin system","volume":"155","author":"Dempsie","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1378\/chest.12-2081_bib10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1152\/jappl.1993.75.1.93","article-title":"Analysis of responses to serotonin in the pulmonary vascular bed of the cat","volume":"75","author":"McMahon","year":"1993","journal-title":"J Appl Physiol"},{"issue":"2","key":"10.1378\/chest.12-2081_bib11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1124\/jpet.104.081182","article-title":"Functional interactions between 5-hydroxytryptamine receptors and the serotonin transporter in pulmonary arteries","volume":"313","author":"Morecroft","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"10.1378\/chest.12-2081_bib12","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1172\/JCI8678","article-title":"Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene","volume":"105","author":"Eddahibi","year":"2000","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1378\/chest.12-2081_bib13","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1172\/JCI200112805","article-title":"Serotonin transporter overexpression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertension","volume":"108","author":"Eddahibi","year":"2001","journal-title":"J Clin Invest"},{"issue":"21","key":"10.1378\/chest.12-2081_bib14","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1161\/CIRCULATIONAHA.104.524926","article-title":"Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats","volume":"111","author":"Guignabert","year":"2005","journal-title":"Circulation"},{"issue":"15","key":"10.1378\/chest.12-2081_bib15","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1161\/01.CIR.0000091409.53101.E8","article-title":"Polymorphism of the serotonin transporter gene and pulmonary hypertension in chronic obstructive pulmonary disease","volume":"108","author":"Eddahibi","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1378\/chest.12-2081_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1472-8206.2004.00195.x","article-title":"Invited review: the evolution of antidepressant mechanisms","volume":"18","author":"Slattery","year":"2004","journal-title":"Fundam Clin Pharmacol"},{"issue":"3","key":"10.1378\/chest.12-2081_bib17","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1161\/01.RES.84.3.329","article-title":"Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin","volume":"84","author":"Eddahibi","year":"1999","journal-title":"Circ Res"},{"issue":"5","key":"10.1378\/chest.12-2081_bib18","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.pupt.2006.01.001","article-title":"Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension","volume":"19","author":"Kawut","year":"2006","journal-title":"Pulm Pharmacol Ther"},{"issue":"3","key":"10.1378\/chest.12-2081_bib19","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1378\/chest.08-2823","article-title":"Selective serotonin reuptake inhibitors and the incidence and outcome of pulmonary hypertension","volume":"136","author":"Shah","year":"2009","journal-title":"Chest"},{"issue":"6","key":"10.1378\/chest.12-2081_bib20","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJMoa052744","article-title":"Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn","volume":"354","author":"Chambers","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1378\/chest.12-2081_bib21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1378\/chest.11-0426","article-title":"Selective serotonin reuptake inhibitors and pulmonary arterial hypertension: a case-control study","volume":"141","author":"Dhalla","year":"2012","journal-title":"Chest"},{"issue":"2","key":"10.1378\/chest.12-2081_bib22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.09-1140","article-title":"Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry","volume":"137","author":"Badesch","year":"2010","journal-title":"Chest"},{"issue":"8","key":"10.1378\/chest.12-2081_bib23","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0025-6196(11)60769-6","article-title":"Design of the REVEAL registry for US patients with pulmonary arterial hypertension","volume":"83","author":"McGoon","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1378\/chest.12-2081_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/01.CIR.0000079172.43229.CD","article-title":"Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction","volume":"108","author":"Sauer","year":"2003","journal-title":"Circulation"},{"issue":"2-3","key":"10.1378\/chest.12-2081_bib25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(97)01393-9","article-title":"Pharmacological profile of antidepressants and related compounds at human monoamine transporters","volume":"340","author":"Tatsumi","year":"1997","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1378\/chest.12-2081_bib26","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0006-3223(01)01145-3","article-title":"Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine","volume":"50","author":"Owens","year":"2001","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1378\/chest.12-2081_bib27","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCULATIONAHA.109.898122","article-title":"Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL)","volume":"122","author":"Benza","year":"2010","journal-title":"Circulation"},{"issue":"4","key":"10.1378\/chest.12-2081_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0033-3182(10)70706-4","article-title":"Depressive symptoms in pulmonary arterial hypertension: prevalence and association with functional status","volume":"51","author":"McCollister","year":"2010","journal-title":"Psychosomatics"},{"issue":"2","key":"10.1378\/chest.12-2081_bib29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/YIC.0b013e3282f2b3dd","article-title":"Ethnicity\/race and the diagnosis of depression and use of antidepressants by adults in the United States","volume":"23","author":"Sclar","year":"2008","journal-title":"Int Clin Psychopharmacol"},{"issue":"14","key":"10.1378\/chest.12-2081_bib30","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1001\/archinte.161.14.1725","article-title":"Depression and risk of heart failure among older persons with isolated systolic hypertension","volume":"161","author":"Abramson","year":"2001","journal-title":"Arch Intern Med"},{"issue":"18","key":"10.1378\/chest.12-2081_bib31","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/CIRCULATIONAHA.107.741058","article-title":"Depressive symptoms and the risk of atherosclerotic progression among patients with coronary artery bypass grafts","volume":"117","author":"Wellenius","year":"2008","journal-title":"Circulation"},{"issue":"20","key":"10.1378\/chest.12-2081_bib32","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1001\/jama.2008.711","article-title":"Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease","volume":"300","author":"Whooley","year":"2008","journal-title":"JAMA"},{"issue":"5","key":"10.1378\/chest.12-2081_bib33","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"5","key":"10.1378\/chest.12-2081_bib34","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/mp.2010.15","article-title":"Macrophage migration inhibitory factor is critically involved in basal and fluoxetine-stimulated adult hippocampal cell proliferation and in anxiety, depression, and memory-related behaviors","volume":"16","author":"Conboy","year":"2011","journal-title":"Mol Psychiatry"},{"issue":"suppl 1","key":"10.1378\/chest.12-2081_bib35","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jacc.2009.04.006","article-title":"Inflammation, growth factors, and pulmonary vascular remodeling","volume":"54","author":"Hassoun","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1378\/chest.12-2081_bib36","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4088\/JCP.v62n0407","article-title":"Effects of nefazodone on body weight: a pooled analysis of selective serotonin reuptake inhibitor- and imipramine-controlled trials","volume":"62","author":"Sussman","year":"2001","journal-title":"J Clin Psychiatry"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369213605292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369213605292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:39:16Z","timestamp":1757918356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369213605292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0012369213605292"],"URL":"https:\/\/doi.org\/10.1378\/chest.12-2081","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Selective Serotonin Reuptake Inhibitors and Outcomes in Pulmonary Arterial Hypertension","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.12-2081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}